Navigation Links
Early Results of the CellCept Spare the Nephron Study Examine,Kidney Function

SAN FRANCISCO, May 07, 2007 /PRNewswire/ -- Interim results from a multicenter trial investigating a novel kidney-sparing treatment protocol using CellCept(R) (mycophenolate mofetil) were presented at the American Transplant Congress. This and other Spare the Nephron (STN) trials in kidney and liver transplant recipients examine ways to prevent rejection without damaging kidneys.

As transplant patients are living longer, doctors are finding that older therapies such as steroids and calcineurin inhibitors (CNIs) can cause impairment of kidney function and damage to the blood vessels and filtering capacity of the kidneys.(1)(2) The STN trials are being conducted at more than 35 transplant centers in the United States and Canada and use CellCept and other immunosuppressants in combinations that reduce or eliminate the use of steroids and CNIs.

"Our goal for the Spare the Nephron trial in kidney transplant recipients is to determine the safest and most effective immunosuppressive therapy regimen that avoids the nephrotoxic effects of CNIs while preventing rejection," said Matthew Weir, M.D., professor and director of the division of nephrology at the University of Maryland School of Medicine. "The preliminary study results are very encouraging."

Dr. Weir reported that first-year results in kidney transplant recipients demonstrated that patients on CellCept and sirolimus maintenance therapy showed improvements in glomerular filtration rate (GFR) of their kidneys without increasing rejection rates.

A total of 208 of 305 kidney transplant patients completed 12 months of follow-up in this open-label, prospective, randomized, multicenter study. Patients initially treated with CellCept and a CNI were randomized to receive CellCept and sirolimus or to continue their current treatment regimen of CellCept and a CNI. Efficacy endpoints included the proportions of patients experiencing acute reject
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
2. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
3. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
4. Promising Data on Cognitive Effects of Safinamide in Early Parkinsons Disease
5. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
6. Clinical Trial Excellence: Shaping Markets Through Early Communication of Clinical Trial Data
7. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
8. Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron
9. Immediate Treatment of Early MS Patients with Betaferon Significantly Delayed Permanent Disability
10. First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability
11. Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women

Post Your Comments:
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--QuestDiagnosticsIncorp...nostictesting,informationandservices,announcedthat...lthcareConferenceinNewYorkCity.Thepresentationissc...nTime. ,, Duringtheconference,thecompanywillrea...%,operatingincometoexceed18%ofrevenues,anddilutede...
(Date:11/24/2009)....J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc.andPf...tration(FDA)hasacceptedforreviewEisai,sNewDrugAppl...lHClextendedrelease)tabletsforthetreatmentofmodera...formulationcontains23mgofdonepezilHClinanextendedr...owsforgradualreleaseofthedrug.TheNDAisbasedonahead...
(Date:11/24/2009).../PRNewswire/--Accumetrics,Inc.,aprivately-helddeve...trapidandeasy-to-usediagnosticsystemformeasuringan....g.Plavix®andaspirin),announcedtodaythatTimot....Tibbitts,ChiefFinancialOfficerofAccumetrics,willb...affrayHealthCareConferencebeingheldinNewYorkCityon...
Breaking Medicine Technology:Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Novel Facebook Application Aims to Prevent Cervical Cancer 59302 1Novel Facebook Application Aims to Prevent Cervical Cancer 59302 2California Walnuts Popular Smart Menus Program Getting Smarter 59297 1California Walnuts Popular Smart Menus Program Getting Smarter 59297 2California Walnuts Popular Smart Menus Program Getting Smarter 59297 3University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 5397 1University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 5397 2University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 5397 3
...YORK, Dec. 13 - The Michael J. Fox,Foundation for ...n for,research toward therapies to alleviate Parki...rders. The funding is to be awarded under a new,in... Parkinson,s Disease,made possible by generous lea...orth America), affiliates of Merck KGaA, Darmstadt...
... Suggest Continued Improvement in Motor Function a...oday presented,long-term follow-up data from a Pha...h advanced Parkinson,s disease. CERE-120 uses gene...urin to the major area of,neurodegeneration that o...s. Long-term follow up assessments at 18 and 24 mo...
Other Medicine Technology:MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders 2MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders 3MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders 4Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 2Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 3Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 4
(Date:11/25/2009)... On more positive note, CDC sees few signs of trou...Y, Nov. 25 (HealthDay News) -- The ongoing H1N1 sw...dangerous pneumonias among younger patients, a U.S...ing an increase in serious pneumococcal infections...of the National Center for Immunization and Respir...
(Date:11/25/2009)...,, ARLINGTON,Va.,Nov.25/PRNewswire-USNewswir...w"PreventHealthCareFraudActof2009,"S.2128,whichisd...labletopreventfraudinMedicare.Thebillwasintroduced...ontainsseveralprovisionstheAmericanAssociationforH...hichtheAssociationproposedtoCongressinFebruary.Tho...
(Date:11/25/2009)..., CAMBRIDGE, Mass. -- A cancer vaccine carried in...sized implant is the first to successfully elimina...in the journal Science Translational Medicine . ,... immunologists at Harvard University, uses plastic...d implanted under the skin to reprogram the mammal...
(Date:11/25/2009)..., The serious behavior problems that can occur in...e reduced with a treatment plan that includes medi... for parents, according to Yale University researc...ecember 2009 issue of the Journal of the American...study was conducted by the National Institute of M...
(Date:11/25/2009)... Study found puffs of air on flesh that mimicked p... , WEDNESDAY, Nov. 25 (HealthDay News) -- Peo...with their skin, new research shows. , In fact,...types of speech actually helped people decipher so...We have never been able to show whether we could u...
Breaking Medicine News(10 mins):Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3
... the age of 64 are,uninsured, CHESTER, Pa., May 1...sic Care, Health Secretary Dr. Calvin B. Johnson,t...nia citizens would have,greatly needed access to a...who attended a public,meeting at Chester City Hall...
...e,increasingly finding value in the research produ...d in particular the use of the on-demand benchmark...http://www.BestPracticeDatabase.com ), Although d...e database. The Best Practice Database not only pr...
...s -- a 30-minute public affairs television program...es of real patients -- will feature Jerry,Mathers,...ver., Mathers is an American icon, best known for...made Jerry Mathers,one of the best-known actors in...
... Care and Consumer-Directed Care, ...etsmart Technologies, Inc., a leading,provider of ...nd human,services organizations, today introduced ...ouncil for Community Behavioral,Healthcare in Bost...
...o Eat Right, Move More and ...ast decade can be defined by,the ups and downs of ... of,fashion like shoulder pads and hemlines. Yet, ...gn crossing the country, the Campaign for Healthy ...
...l/ - Haemacure Corporation (TSX :,HAE), a Montreal...ng,high-value human plasma-derived protein product...h Galli, Chairman and Chief Executive Officer,will...ce 2008 is the Canadian Life Science industry,s le...
Other Medicine News:Health News:State Health Secretary Visits City of Chester for 'Cover the Uninsured' Week 2Health News:Marketing Executives Finding Value in Best Practice Database 2Health News:'Sharing Miracles' Television Program to Feature Leave it to Beaver Star Jerry Mathers 2Health News:'Sharing Miracles' Television Program to Feature Leave it to Beaver Star Jerry Mathers 3Health News:'Sharing Miracles' Television Program to Feature Leave it to Beaver Star Jerry Mathers 4Health News:'Sharing Miracles' Television Program to Feature Leave it to Beaver Star Jerry Mathers 5Health News:Netsmart Technologies Introduces the Netsmart Connect(TM) Suite of Solutions for Behavioral and Public Healthcare 2Health News:Netsmart Technologies Introduces the Netsmart Connect(TM) Suite of Solutions for Behavioral and Public Healthcare 3Health News:Message to Tucson Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Tucson Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Message to Tucson Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 4Health News:Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008 2
BLF21 Single Channel
Oxyflo 2000
Multi Dop X4
Multi Dop L1
Medicine Products: